Related Experiment Video
Updated: Dec 11, 2025

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
Protease-activated receptor 4 causes Akt phosphorylation independently of PI3 kinase pathways
Carol Dangelmaier1, Satya P Kunapuli1
1Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Abstract:
PI-3 Kinase plays an important role in platelet activation mainly through regulation of RASA3. Akt phosphorylation is an indicator for the activity of PI3 kinase. The aim of this study is to characterize the pathways leading to Akt phosphorylation in platelets. We performed concentration response curves of LY294002, a pan-PI3 kinase inhibitor, on platelet aggregation and Akt phosphorylation, in washed human and mouse platelets. At concentrations as low as 3.12 µM, LY294002 abolished Akt phosphorylation induced by 2MeSADP and SFLLRN, but not by AYPGKF. It required much higher concentrations of LY294002 (12.5-25 µM) to abolish AYPGKF-induced Akt phosphorylation, both in wild type and P2Y12 null mouse platelets. We propose that 3.12 µM LY294002 is sufficient to inhibit PI3 kinase isoforms in platelets and higher concentrations might inhibit other pathways regulating Akt phosphorylation by AYPGKF. We conclude that Protease-activated receptor 4 (PAR4) might cause Akt phosphorylation through pathways distinctly different from those of Protease-activated receptor 1 (PAR1).
Insights
Phosphoinositide 3-kinase (PI3K) regulates platelet activation. This study reveals distinct pathways for Akt phosphorylation induced by Protease-activated receptor 1 (PAR1) versus Protease-activated receptor 4 (PAR4) agonists.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Phosphoinositide 3-kinase (PI3K) is crucial for platelet activation, primarily via RASA3 regulation.
- Akt phosphorylation serves as a key indicator of PI3K activity within platelets.
Purpose of the Study:
- To elucidate the specific signaling pathways responsible for Akt phosphorylation in platelets.
- To differentiate the mechanisms of Akt activation by various platelet agonists.
Main Methods:
- Concentration-response experiments using LY294002, a PI3K inhibitor, were conducted on human and mouse platelets.
- Platelet aggregation and Akt phosphorylation levels were measured following stimulation with agonists like 2MeSADP, SFLLRN, and AYPGKF.
Main Results:
- Low LY294002 concentrations (3.12 µM) inhibited Akt phosphorylation induced by 2MeSADP and SFLLRN (PAR1 agonists).
- Higher LY294002 concentrations (12.5–25 µM) were required to inhibit Akt phosphorylation induced by AYPGKF (PAR4 agonist), irrespective of P2Y12 receptor status.
- These findings suggest that PI3K isoforms are inhibited at low LY294002 concentrations, while higher doses may affect alternative pathways.
Conclusions:
- Protease-activated receptor 4 (PAR4) mediates Akt phosphorylation through signaling cascades distinct from those activated by Protease-activated receptor 1 (PAR1).
- The study highlights the differential regulation of Akt phosphorylation in platelets by various receptor pathways.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
Receptor Tyrosine Kinases
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

